TLR4 and pulmonary arterial hypertension: Importantly, the increased expression of TLR4 activates the classical NF‐κB inflammatory signalling pathway, thereby mediating endothelial cell inflammation within pulmonary arteries and emerging as one of the principal factors driving the pathogenesis of PAH.112